Mark Zylstra

Director of Regulatory Affairs at Mazen Animal Health - Oral Vaccines
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Humboldt, Iowa, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Director of Regulatory Affairs
      • Jan 2021 - Present
    • Consultant
      • Jan 2019 - Present
    • 1 - 100 Employee
      • Jan 2018 - Jan 2021

      Direct multi-site team of 15 responsible for assay development for large molecule portfolio including vaccine, biopharmecutical, nutritional, and enzyme products. Analytical methods include in-process, characterization, purity, and potency assays for process monitoring and release of commercial serials.

      • Mar 2017 - Jan 2018

      Direct team of 17 responsible for analytical development and process development for veterinary vaccines. In-coming transfer of early phase methods and processes from Research team at another site. Transfer of developed methods and processes into QC and Manufacturing.

      • Jan 2017 - Mar 2017

      Direct staff responsible for innovation and post-license regulatory activities for companion animal vaccines. Obtain USDA approval for 64 acquired products and related facilities. Regulatory responsibility for product transfers out of and into the site. Represent Elanco on technical transfer team comprised of Elanco, BIVI, Merial, and Federal Trade Commission. Leadership role on Ft. Dodge site Transition Team.

    • Senior Associate Director International Regulatory Affairs
      • Aug 2010 - Dec 2016

      Direct staff of 15 responsible for all NAFTA pre and post-license regulatory activities for veterinary vaccines for all species. Work with Quality leads to represent firm in issues resolution with USDA CVB. From 2010-2014 this team was issued the most new USDA product licenses of all US firms. Direct staff of 15 responsible for all NAFTA pre and post-license regulatory activities for veterinary vaccines for all species. Work with Quality leads to represent firm in issues resolution with USDA CVB. From 2010-2014 this team was issued the most new USDA product licenses of all US firms.

    • Associate Director, International Regulatory Affairs
      • Dec 2009 - Aug 2010

      Directed staff of 8-10 responsible for all NAFTA regulatory activities for companion animal vaccines. Facilitate transfer of 120 vaccine product licenses (former FDAH products) from Pfizer Animal Health (PAH). Serve as liaison with joint team of USDA CVB, FTC, PAH, and BIVI to ensure efficient transfer of divested assets. Directed staff of 8-10 responsible for all NAFTA regulatory activities for companion animal vaccines. Facilitate transfer of 120 vaccine product licenses (former FDAH products) from Pfizer Animal Health (PAH). Serve as liaison with joint team of USDA CVB, FTC, PAH, and BIVI to ensure efficient transfer of divested assets.

      • Feb 2002 - Nov 2009

      Directed staff of 8-10 responsible for all USDA and CFIA regulatory activities. Included new product registration, defense of licensed products, facilities documents, label approval and submission, review of advertising/ promotional material, and import permit acquisition. Managed registration activities resulting in 112 new USDA product licenses that included the world's first DNA vaccine license, the firm's first recombinant vaccine registration in Canada, and three-year duration of immunity claims for vaccines. Show less

      • Jun 2000 - Feb 2002

      Establish formal training department for 1200 employees at three sites. Responsible for coordinating, conducting, and tracking training for all employees including regulatory compliance, SOPs, supervisor and leadership skills, office suite software, and new employee orientation.

      • Feb 1999 - Jun 2000

      Responsible for all aspects of manufacturing of veterinary biologics and sterile injectable pharmaceuticals. Directed team of seventy-five union production employees and fifty technical, supervisory, management, and administrative staff. Coordination and prioritization of operations activities to meet aggressive product demands with minimal staffing.

      • Feb 1999 - Jun 2000

      Oversight of team responsible for preparation and sterilization of viral and bacterial growth media and equipment. USDA/USP/EU compliance for raw material procurement and testing. Consolidation and rationalization of raw materials, solutions, and methods between manufacturing sites (due to acquisition).

      • Feb 1993 - Apr 1998

      Oversight of team responsible for preparation and sterilization of viral and bacterial growth media and equipment. USDA/USP/EU compliance for raw material procurement and testing.

      • Jul 1989 - Feb 1993

      Oversight of technicians conducting in-process and serial release testing of veterinary biologics. Preparation and review of documents submitted in support of release of commercial serials by USDA.

      • Feb 1987 - Jul 1989

      Preparation, expansion, storage, and documentation of working seed virus stocks to provide to manufacturing team.

      • Nov 1982 - Feb 1987

      • Jun 1981 - Nov 1982

      Operation and monitoring of manufacturing scale fermentation equipment.

      • May 1980 - Jun 1981

      Supervise union employees operating packing equipment for veterinary vaccines and filling equipment for veterinary pharmaceuticals.

Education

  • Westmar College
    Bachelor of Arts - BA, Biology/Biological Sciences, General
    1976 - 1980

Community

You need to have a working account to view this content. Click here to join now